Preparation and Evaluation of Solid Dispersion-Based Bilastine Effervescent Granules

Mariam Hamid Ali; Kawthar Khalid Ahmed

doi:10.54133/ajms.v6i2.806

Authors

Mariam Hamid Ali Kirkuk Health Directorate, Iraqi Ministry of Health, Kirkuk, Iraq https://orcid.org/0009-0002-2600-7916
Kawthar Khalid Ahmed Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq

DOI:

https://doi.org/10.54133/ajms.v6i2.806

Keywords:

Bilastine, Effervescent granules solid dispersion, Kneading technique, PVP K30, PLX188

Abstract

Background: Bilastine (BLA) is a second-generation H1 antihistamine used to treat allergic rhinoconjunctivitis. Because of its limited solubility, it falls under class II of the Biopharmaceutics Classification System (BSC). The solid dispersion (SD) approach significantly improves the solubility and dissolution rate of insoluble medicines. Objective: To improve BLA solubility and dissolution rate by formulating a solid dispersion in the form of effervescent granules. Methods: To create BLA SDs, polyvinylpyrrolidone (PVP K30) and poloxamer 188 (PLX188) were mixed in various ratios (1:5, 1:10, and 1:15) using the kneading technique. All formulations were evaluated based on percent yield, drug content, and saturation solubility. The formulae with the greatest solubility enhancement were subjected to in vitro dissolution studies, Fourier transform infrared, and thermal analysis to study drug crystallinity and drug-polymer interactions. The best SD formula was made as effervescent granules using wet granulation and tested further. Results: The SD3 formula, which contained PVP K30 in a 1:15 ratio, had the highest solubility and release. In phosphate buffer (pH 6.8), over 88.43% of the BLA was released within the first 15 minutes. The optimum formula's effervescent granules demonstrated excellent flow qualities, a disintegration time of 87 seconds, an acceptable pH of 5.9, and 9.7 mg of BLA dissolved in the first 5 minutes. Conclusions: BLA dissolution can be improved via the solid dispersion technique, allowing for successful effervescent granule formulation.

Downloads

Download data is not yet available.

References

Ruba Malkawi WIM, Mahmoud Y, Tawalbeh J. Current trends on solid dispersions: past, present, and future. Adv Pharmacol Pharm Sci. 2022;2022:5916013. doi: 10.1155/2022/5916013.

De Mohac LM, Raimi-Abraham B, Caruana R, Gaetano G, Licciardi M. Multicomponent solid dispersion a new generation of solid dispersion produced by spray-drying. J Drug Deliv Sci Technol. 2020;57:101750. doi: 10.1016/j.jddst.2020.101750.

Nikghalb LA, Singh G, Singh G, Kahkeshan KF. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012;2(10):170-175. doi: 10.7324/JAPS.2012.21031.

Shankarguru P, Ramya Ddevi D, Hari Bn V. Effect of water content in kneading method of solid dispersion technique for solubility enhancement. Int J App Pharm. 2017;9. doi: 10.22159/ijap.2017v9i5.17765.

Hatem AQ, Ali WK. Preparation and characterization of carvedilol solid dispersion by kneading method. Al Mustansiriyah J Pharm Sci. 2023;23:367-377. doi: 10.32947/ajps.v23i4.1092.

Leceta A, García A, Sologuren A, Campo C. Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions. Drugs Context. 2021;10:1-15. doi: 10.7573/dic.2021-5-1.

Nechipadappu SK, Swain D. Combined synthetic and solubility aspects of orotate salt of bilastine. J Mol Struct. 2023;1271:1-4. doi; 10.1016/j.molstruc.2022.134148.

Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech. 2009;10(4):1206-1215. doi: 10.1208/s12249-009-9316-0.

Jejurkar L, Tapar KK. Preparation and characterization of mesalamine solid dispersions by kneading method. IJPSR. 2011;2(10):2623-2628. doi: 10.13040/IJPSR.0975-8232.2(10).2623-28.

Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech. 2017;7(3):68. doi; 10.1208%2Fpt070368.

Al-Khedairy EB, Hussein LS. Solubility and dissolution enhancement of ebastine by surface solid dispersion technique. Iraqi J Pharm Sci. 2021;30:122-132. doi: 10.31351/vol30iss1pp122-132.

Eltayeeb A, Al-Khedairy EB. Preparation and evaluation of aceclofenac solid dispersion by fusion technique and effervescent assisted fusion technique: comparative study. Res J Pharm Technol. 2023:5358-5365. doi: 10.52711/0974-360X.2023.00868.

Rekha K, Aruna RM, Rekha MM, Karthik S. Formulation and development of bilastine tablets 20 mg. World J Pharm Res. 2019;8:2197-224.

Ahmed KK, Kassab HJ, Al Ramahi IJ, Alwan ZS. Taste masking of steroids for oral formulations. Turk J Pharm Sci. 2024;20(6):352-360. doi: 10.4274/tjps.galenos.2023.24968.

Salim FF, Rajab NA. Formulation and characterization of piroxicam as self-nano emulsifying drug delivery system. Iraqi J Pharm Sci. 2020;29:174-183. doi: 10.31351/vol29iss1pp174-183.

Hussein ZK, Al-Kinani KK. Formulation and evaluation of the risperidone solid dispersion using different carriers. J Res Med Dent Sci. 2023;7:26-34.

Divya K, Vamshi G, Vijaykumar T, Rani MS, Kishore B. Review on introduction to effervescent tablets and granules. Kenkyu J Pharmacol. 2020;6:1-9.

Al-Mousawy J, Al-Hussainy Z, Alaayedi M. Formulation and evaluation of effervescent granules of ibuprofen. Int J Appl Pharm. 2019:66-69. doi: 10.22159/ijap.2019v11i6.34912.

Alwan ZS, Ibrahim MA. Study the effect of disintegrant types on preparation and in vitro evaluation of salbutamol sulfate effervescent granules. Kerbala J Pharm Sci. 2021;1(19):1-9.

Sangram Biranje AM, Trusha P, Shangrapawar AB. A review on formulation and evaluation of effervescent tablet. IJPPR. 2021;21:477-486.

Diyya ASM, Thomas NV. Formulation and evaluation of metronidazole effervescent granules. Int J Pharm Sci Res. 2018;9:2525-2529. doi: 10.13040/IJPSR.0975-8232.9(6).2525-29.

Basavaraj VB, Saritha N, Bharath S, Madhavan V. Vigna mungo mucilage- a natural polymer in the design of matrix based SR tablet of aceclofenac. Int J Pharm Sci Rev Res. 2013;21(2).

Sonawane A, Sudhir S, Pathak RCP. Effect of drying on physical and flow properties of banana powder. Carpathian J Food Sci Technol. 2021:174-185. doi: 10.34302/crpjfst/2021.13.3.14.

Ayan Pani SP, Kanthal LK, Bera M, Jana P, Samanta S, Izaz Ahmed Khan IA, et al. A comparative assessment of granulation methods containing effervescent granules of vitamin C. J Res Pharm Sci. 2022;8(2022):32-39.

Aslani A, Fattahi F. Formulation, characterization and physicochemical evaluation of potassium citrate effervescent tablets. Adv Pharm Bull. 2013;3(1):217-225. doi: 10.5681%2Fapb.2013.036.

Hussain HAM, Al-Khedairy EB. Preparation and in vitro evaluation of cyclodextrin based effervescent and dispersible granules of carbamazepine. Int J Appl Pharm. 2018;10(6). doi: 10.22159/ijap.2018v10i6.28276.

Abbas IK, Al Hammid SNA. Preparation and characterization of bilastine solid self- nanoemulsion using liquisolid technique. Al-Rafidain J Med Sci. 2023;5:78-85. doi: 10.54133/ajms.v5i.160.

Ladhake V, Kadu S, Tayade V, Gawand S, Malviya V. Preparation and evaluation of oral fast dissolving films of bilastine using pullulan. IJSDR. 2020;5:282-287.

El Maghraby GM, Elsergany RN. Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Devel Technol. 2014;19(6):641-650. doi: 10.3109/10837450.2013.813543.

Ardiansyah A, Nasrul E, Rivai H, Sahlan Ben E, Zaini E. Physicochemical characterization of amorphous solid dispersion of ketoprofen–polyvinylpyrrolidone k-30. Int J Pharmacy Pharm Sci. 2014;7:209-212.

Liu P, Zhou JY, Chang JH, Liu XG, Xue HF, Wang RX, et al. Soluplus-mediated diosgenin amorphous solid dispersion with high solubility and high stability: development, characterization and oral bioavailability. Drug Des Dev Ther. 2020;14:2959-2975. doi: 10.2147%2FDDDT.S253405.

harma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 2010;5(1):49-56. PMID: 21589768.

Sharannavar BR, Gadad AP. Physicochemical characterization and dissolution study of spray dried amorphous lovastatin with Polyvinylpyrrolidone K30. Pharma Innov J. 2018;7(3):498-502.

Liw JJ, Teoh XY, Teoh AXY, Chan SY. The effect of carrier-drug ratios on dissolution performances of poorly soluble drug in crystalline solid dispersion system. J Pharm Sci. 2022;111(1):95-101. doi: 10.1016/j.xphs.2021.06.026.

Jassim BM, Al-Khedairy EB. Enhancement of silymarin solubility and dissolution by nicotinamide-based solid dispersion employing the kneading method. JPTCP. 2023;30(13). doi: 10.47750/jptcp.2023.30.13.028.

Rusdin A, Mohd Gazzali A, Ain Thomas N, Megantara S, Aulifa DL, Budiman A, et al. Advancing drug delivery paradigms: Polyvinyl pyrolidone (PVP)-based amorphous solid dispersion for enhanced physicochemical properties and therapeutic efficacy. Polymers (Basel). 2024;16(2):286. doi: 10.3390/polym16020286.

Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 2014;17(5):322-331. PMID: 24967060.

Noolkar SB, Jadhav NR, Bhende SA, Killedar SG. Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions. AAPS PharmSciTech. 2013;14(2):569-577. doi: 10.1208/s12249-013-9941-5.

Bashar KKG, Al-Khedairy EB. Solubility and dissolution enhancement of atorvastatin calcium using phospholipid solid dispersion technique. Iraqi J Pharm Sci. 2023;32:244-253. doi: 10.31351/vol32issSuppl.pp244-253.

Del Río Pericacho JL, Lopez RP, Arredondo Martinez YE. Crystalline forms of bilastine and preparation methods thereof. European Patent Application (EP 3 327 012 A1). 2018.

Iyer R, Petrovska Jovanovska V, Berginc K, Jaklič M, Fabiani F, Harlacher C, et al. Amorphous solid dispersions (ASDs): The influence of material properties, manufacturing processes and analytical technologies in drug product development. Pharmaceutics. 2021;13(10):1682. doi: 10.3390/pharmaceutics13101682.

Rosiak N, Wdowiak K, Tykarska E, Cielecka-Piontek J. Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases. Int J Mol Sci. 2022;23(23):15198. doi: 10.3390/ijms232315198.

Huynh DTM, Hai HT, Hau NM, Lan HK, Vinh TP, Tran V, et al. Preparations and characterizations of effervescent granules containing azithromycin solid dispersion for children and elder: Solubility enhancement, taste-masking, and digestive acidic protection. Heliyon. 2023;9(6):e16592. doi: 10.1016/j.heliyon.2023.e16592.

Attebäck M, Hedin B, Mattsson S. Formulation, optimization of extemporaneous oral liquids containing naloxone and propranolol for pediatric use. Scientia Pharmaceutica. 2022;90(1). doi: 10.3390/scipharm90010015.